Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

136
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
136
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

450
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
450
Survival Curves01:18

Survival Curves

171
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
171
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

251
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
251

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoplasmic reticulum stress in antitumor immunity and immunotherapy resistance: mechanisms and therapeutic implications.

Molecular cancer·2026
Same author

Retraction notice to "Liposomal honokiol promotes hair growth via activating Wnt3a/β-catenin signaling pathway and down regulating TGF-β1 in C57BL/6N mice" [Biomedicine & Pharmacotherapy 141 (2021) 111793].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Electrospun Flexible Ceramic Nanofibers: Toward High-Performance Materials for Multifunctional Applications.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Randomized Trial of Adjunctive Prednisolone for Kawasaki Disease.

The New England journal of medicine·2026
Same author

Performance Enhancement of Amorphous Soft Magnetic Composites by Synergistic Warm Compaction and Fine FeNi Powders Addition.

Materials (Basel, Switzerland)·2026
Same author

Per- and polyfluoroalkyl substances and cardiovascular disease: A mechanistic and epidemiological synthesis.

Ecotoxicology and environmental safety·2026

Related Experiment Video

Updated: Jul 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Multiply robust estimator for the difference in survival functions using pseudo-observations.

Ce Wang1, Kecheng Wei1, Chen Huang1

  • 1Department of Biostatistics, Key Laboratory for Health Technology Assessment, National Commission of Health, Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, Fudan University, Shanghai, China.

BMC Medical Research Methodology
|October 23, 2023
PubMed
Summary

This study introduces a new multiply robust estimator for survival outcomes, offering improved accuracy by allowing multiple model choices. The method accurately estimates treatment effects, even with imperfect data, benefiting observational studies.

Keywords:
Empirical likelihoodMultiply robustPropensity scoreSurvival functionSurvival outcome

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K

Related Experiment Videos

Last Updated: Jul 12, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Causal Inference

Background:

  • Estimating causal effects on survival in observational studies requires adjusting for confounding factors due to covariate imbalances.
  • Existing methods lack a multiply robust approach for estimating differences in survival functions.
  • A novel multiply robust (MR) estimator is proposed, integrating multiple propensity score and outcome regression models for enhanced protection.

Purpose of the Study:

  • To develop and evaluate a new multiply robust estimator for the difference in survival functions in observational studies.
  • To provide a method that offers robustness against model misspecification in propensity score and outcome regression models.
  • To assess the performance of the proposed estimator through simulation studies and application to real-world cancer data.

Main Methods:

  • A new multiply robust (MR) estimator was developed, building upon previous work (Han 2014) and incorporating the pseudo-observation approach.
  • The proposed MR estimator allows for the simultaneous use of multiple propensity score (PS) and outcome regression (OR) models.
  • A Monte Carlo simulation study was conducted to evaluate the estimator's bias and coverage rates under various scenarios, including proportional hazards assumption violations.
  • The estimator was applied to real-world data to assess the effect of chemotherapy on triple-negative breast cancer (TNBC) survival.

Main Results:

  • Simulation studies demonstrated that the proposed MR estimator exhibits small bias and coverage rates close to 95% when at least one PS or OR model is correctly specified, irrespective of the proportional hazards assumption, sample size, or censoring rate.
  • Even with misspecified propensity score models, the estimator maintained small bias if a correct outcome regression model was included.
  • Application to real data indicated that chemotherapy improves the prognosis for triple-negative breast cancer (TNBC).

Conclusions:

  • The proposed multiply robust estimator offers enhanced protection for estimating differences in survival functions by accommodating multiple model specifications.
  • This method provides a valuable alternative for researchers facing challenges in selecting a single model for their survival analysis.
  • The findings suggest that the MR estimator is a reliable tool for causal inference in survival analysis, particularly in complex observational settings.